Hypoxia and Intestinal Inflammation: Common Molecular Mechanisms and Signaling Pathways

The gastrointestinal tract (GI) has a unique oxygenation profile. It should be noted that the state of hypoxia can be characteristic of both normal and pathological conditions. Hypoxia-inducible factors (HIF) play a key role in mediating the response to hypoxia, and they are tightly regulated by a group of enzymes called HIF prolyl hydroxylases (PHD). In this review, we discuss the involvement of inflammation hypoxia and signaling pathways in the pathogenesis of inflammatory bowel disease (IBD) and elaborate in detail on the role of HIF in multiple immune reactions during intestinal inflammation. We emphasize the critical influence of tissue microenvironment and highlight the existence of overlapping functions and immune responses mediated by the same molecular mechanisms. Finally, we also provide an update on the development of corresponding therapeutic approaches that would be useful for treatment or prophylaxis of inflammatory bowel disease.

[1]  A. Piotrowska,et al.  Etiology of IBD—Is It Still a Mystery? , 2022, International journal of molecular sciences.

[2]  C. Taylor,et al.  Hypoxia-inducible factor (HIF) as a bridge between healthy barrier function, wound healing, and fibrosis. , 2022, American journal of physiology. Cell physiology.

[3]  A. Bäumler,et al.  The microbiome and gut homeostasis , 2022, Science.

[4]  Sen Li,et al.  Phytochemicals targeting Toll-like receptors 4 (TLR4) in inflammatory bowel disease , 2022, Chinese Medicine.

[5]  K. Allin,et al.  Multiomics to elucidate inflammatory bowel disease risk factors and pathways , 2022, Nature Reviews Gastroenterology & Hepatology.

[6]  R. Wenger,et al.  The asparagine hydroxylase FIH - a unique oxygen sensor. , 2022, Antioxidants & redox signaling.

[7]  Shuo Liang,et al.  ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer , 2021, Journal of Experimental & Clinical Cancer Research.

[8]  B. Bošnjak,et al.  Imaging dendritic cell functions * , 2021, Immunological reviews.

[9]  D. McKernan Toll-Like Receptors as Drug Targets in the Intestinal Epithelium. , 2021, Handbook of experimental pharmacology.

[10]  Yan Zhu,et al.  Antimicrobial Peptides: An Update on Classifications and Databases , 2021, International journal of molecular sciences.

[11]  Hua Yang,et al.  The role of hypoxia‐inducible factor 1‐alpha in inflammatory bowel disease , 2021, Cell biology international.

[12]  I. Baranowska-Bosiacka,et al.  Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-κB Activation: A Review of the Molecular Mechanisms , 2021, International journal of molecular sciences.

[13]  Martin Wah,et al.  Inflammatory bowel disease: The role of commensal microbiome in immune regulation , 2021, Gastroenterologia y hepatologia.

[14]  M. Veldhoen,et al.  Regulation of Oxygen Homeostasis at the Intestinal Epithelial Barrier Site , 2021, International journal of molecular sciences.

[15]  Yitao Wang,et al.  HIF-1: structure, biology and natural modulators. , 2021, Chinese journal of natural medicines.

[16]  Hai Hu,et al.  The Roles of 2-Hydroxyglutarate , 2021, Frontiers in Cell and Developmental Biology.

[17]  Zhi-yun Chen,et al.  The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease , 2020, Journal of immunology research.

[18]  J. Fandrey,et al.  The Importance of Hypoxia-Inducible Factors (HIF-1 and HIF-2) for the Pathophysiology of Inflammatory Bowel Disease , 2020, International journal of molecular sciences.

[19]  A. Bergthaler,et al.  Systemic Immunometabolism: Challenges and Opportunities , 2020, Immunity.

[20]  Hua Yang,et al.  SCFAs induce autophagy in intestinal epithelial cells and relieve colitis by stabilizing HIF-1α , 2020, Journal of Molecular Medicine.

[21]  Y. Shah,et al.  Oxygen battle in the gut: Hypoxia and hypoxia-inducible factors in metabolic and inflammatory responses in the intestine , 2020, The Journal of Biological Chemistry.

[22]  S. Rocha,et al.  HIF-1β Positively Regulates NF-κB Activity via Direct Control of TRAF6 , 2020, International journal of molecular sciences.

[23]  H. Fan,et al.  Cronobacter sakazakii induces necrotizing enterocolitis by regulating NLRP3 inflammasome expression via TLR4. , 2020, Journal of medical microbiology.

[24]  K. Fitzgerald,et al.  Toll-like Receptors and the Control of Immunity , 2020, Cell.

[25]  Ahmad Esmaillzadeh,et al.  A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial , 2020, Trials.

[26]  C. Taylor,et al.  Hypoxia and Innate Immunity: Keeping Up with the HIFsters. , 2020, Annual review of immunology.

[27]  H. Jasper Intestinal Stem Cell Aging: Origins and Interventions. , 2020, Annual review of physiology.

[28]  F. Carbone,et al.  Molecular Mechanisms Controlling Foxp3 Expression in Health and Autoimmunity: From Epigenetic to Post-translational Regulation , 2020, Frontiers in Immunology.

[29]  H. Vlamakis,et al.  Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial. , 2019, Inflammatory bowel diseases.

[30]  E. Sanders,et al.  Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life , 2019, Nature Communications.

[31]  K. Murphy,et al.  Shared Transcriptional Control of Innate Lymphoid Cell and Dendritic Cell Development. , 2019, Annual review of cell and developmental biology.

[32]  P. Gibson,et al.  Intestinal gases: influence on gut disorders and the role of dietary manipulations , 2019, Nature Reviews Gastroenterology & Hepatology.

[33]  K. Garey,et al.  Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways , 2019, mBio.

[34]  C. Germer,et al.  Neurotrophic factor GDNF regulates intestinal barrier function in inflammatory bowel disease. , 2019, The Journal of clinical investigation.

[35]  C. Taylor,et al.  Hypoxia-inducible factor (HIF) hydroxylase inhibition enhances the protective effects of cyclosporine in colitis. , 2019, American journal of physiology. Gastrointestinal and liver physiology.

[36]  Hua Yang,et al.  Intestinal Epithelial Cells-Derived Hypoxia-Inducible Factor-1α Is Essential for the Homeostasis of Intestinal Intraepithelial Lymphocytes , 2019, Front. Immunol..

[37]  Hu Zhang,et al.  NLRP3 Inflammasome and Inflammatory Bowel Disease , 2019, Front. Immunol..

[38]  Jeff F Dunn,et al.  Partial pressure of oxygen in the human body: a general review. , 2019, American journal of blood research.

[39]  S. Walmsley,et al.  Inflammation and Hypoxia: HIF and PHD Isoform Selectivity. , 2019, Trends in molecular medicine.

[40]  R. Ardy,et al.  Early‐onset inflammatory bowel disease as a model disease to identify key regulators of immune homeostasis mechanisms , 2018, Immunological reviews.

[41]  Nupur K. Das,et al.  Hepatic hepcidin/intestinal HIF-2&agr; axis maintains iron absorption during iron deficiency and overload , 2018, The Journal of clinical investigation.

[42]  D. Philpott,et al.  NOD1 and NOD2 in inflammation, immunity and disease. , 2019, Archives of biochemistry and biophysics.

[43]  J. Doré,et al.  Mucosal healing and bacterial composition in response to enteral nutrition versus steroid based induction therapy - a randomized prospective clinical trial in children with Crohn's disease. , 2018, Journal of Crohn's & colitis.

[44]  Zhihui Feng,et al.  Modulation of HIF-2α PAS-B domain contributes to physiological responses , 2018, Proceedings of the National Academy of Sciences.

[45]  A. Petersen,et al.  Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease , 2018, Front. Med..

[46]  W. Strober,et al.  The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel Disease , 2018, Front. Immunol..

[47]  F. Gonzalez,et al.  The role of hypoxia-inducible factors in metabolic diseases , 2018, Nature Reviews Endocrinology.

[48]  J. Allaire,et al.  The Intestinal Epithelium: Central Coordinator of Mucosal Immunity. , 2018, Trends in immunology.

[49]  L. Lartigue,et al.  Metabolic Stress in the Immune Function of T Cells, Macrophages and Dendritic Cells , 2018, Cells.

[50]  Yajin Zhao,et al.  Nitric oxide in red blood cell adaptation to hypoxia , 2018, Acta biochimica et biophysica Sinica.

[51]  C. Stockmann,et al.  Hypoxia, Metabolism and Immune Cell Function , 2018, Biomedicines.

[52]  Katsuaki Sato,et al.  The HDAC Inhibitor, SAHA, Prevents Colonic Inflammation by Suppressing Pro-inflammatory Cytokines and Chemokines in DSS-induced Colitis , 2018, Acta histochemica et cytochemica.

[53]  C. Elly,et al.  E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function via Glycolysis Inhibition and Induction of Interleukin‐33 Receptor , 2018, Immunity.

[54]  Andrew J. Oler,et al.  Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn’s disease , 2018, The Journal of clinical investigation.

[55]  L. Van Kaer,et al.  Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier. , 2017, Trends in immunology.

[56]  C. Taylor,et al.  Hypoxia‐sensitive pathways in intestinal inflammation , 2017, The Journal of physiology.

[57]  A. Harris,et al.  Advances in Hypoxia-Inducible Factor Biology. , 2017, Cell metabolism.

[58]  C. Taylor Hypoxia in the Gut , 2017, Cellular and molecular gastroenterology and hepatology.

[59]  J. Danesh,et al.  NOX1 loss-of-function genetic variants in patients with inflammatory bowel disease , 2017, Mucosal Immunology.

[60]  G. Schett,et al.  Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune disease , 2018, Nature Communications.

[61]  M. Veldhoen,et al.  Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases , 2018, Nature Communications.

[62]  J. Fandrey,et al.  Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis , 2017, PloS one.

[63]  W. D. de Vos,et al.  C4B gene influences intestinal microbiota through complement activation in patients with paediatric‐onset inflammatory bowel disease , 2017, Clinical and experimental immunology.

[64]  Y. Shoenfeld,et al.  Adverse effects of gluten ingestion and advantages of gluten withdrawal in nonceliac autoimmune disease , 2017, Nutrition reviews.

[65]  J. Bergh,et al.  An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression , 2017, Cancer cell.

[66]  Yuehua Wu,et al.  Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis , 2017, Nature Medicine.

[67]  P. Carmeliet,et al.  Opposing regulation and roles for PHD3 in lung dendritic cells and alveolar macrophages , 2017, Journal of leukocyte biology.

[68]  R. Wenger,et al.  Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation , 2017, Nature Communications.

[69]  P. Maxwell,et al.  Hypoxia and B cells. , 2017, Experimental cell research.

[70]  J. Raes,et al.  The resilience of the intestinal microbiota influences health and disease , 2017, Nature Reviews Microbiology.

[71]  L. Figueiredo Faculty Opinions recommendation of HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. , 2017 .

[72]  Xiuli Liu,et al.  IL-10 and IL-10 Receptor Mutations in Very Early Onset Inflammatory Bowel Disease , 2017, Gastroenterology research.

[73]  Fabian Rivera-Chávez,et al.  Oxygen as a driver of gut dysbiosis. , 2017, Free radical biology & medicine.

[74]  G. Zhou,et al.  Hypoxia inducible factor‐1α‐induced interleukin‐33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease , 2017, Clinical and experimental immunology.

[75]  P. Carmeliet,et al.  Haematopoietic prolyl hydroxylase‐1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis , 2017, The Journal of pathology.

[76]  J. Turner,et al.  The intestinal epithelial barrier: a therapeutic target? , 2017, Nature Reviews Gastroenterology &Hepatology.

[77]  Inkyung Jung,et al.  Epithelial Hypoxia-Inducible Factor 2α Facilitates the Progression of Colon Tumors through Recruiting Neutrophils , 2016, Molecular and Cellular Biology.

[78]  E. Cummins,et al.  Hypoxia-dependent regulation of inflammatory pathways in immune cells. , 2016, The Journal of clinical investigation.

[79]  L. O’Neill,et al.  HIF1α and metabolic reprogramming in inflammation. , 2016, The Journal of clinical investigation.

[80]  Ariel L. Raybuck,et al.  Germinal Center hypoxia and regulation of antibody qualities by a hypoxia response system , 2016, Nature.

[81]  E. Campbell,et al.  Hypoxia and Mucosal Inflammation. , 2016, Annual review of pathology.

[82]  S. Ramakrishnan,et al.  Role of Intestinal HIF-2α in Health and Disease. , 2016, Annual review of physiology.

[83]  P. Ratcliffe,et al.  Pharmacological targeting of the HIF hydroxylases--A new field in medicine development. , 2016, Molecular aspects of medicine.

[84]  R. Deberardinis,et al.  TCA Cycle and Mitochondrial Membrane Potential Are Necessary for Diverse Biological Functions. , 2016, Molecular cell.

[85]  E. Mills,et al.  Reprogramming mitochondrial metabolism in macrophages as an anti‐inflammatory signal , 2016, European journal of immunology.

[86]  J. Fandrey,et al.  Hypoxia-inducible factor 1 in dendritic cells is crucial for the activation of protective regulatory T cells in murine colitis , 2015, Mucosal Immunology.

[87]  M. Ohh,et al.  Hydroxylation-Dependent Interaction of Substrates to the Von Hippel-Lindau Tumor Suppressor Protein (VHL). , 2016, Methods in molecular biology.

[88]  Jianquan Hou,et al.  Hypoxia-Inducible Factor-2α Limits Natural Killer T Cell Cytotoxicity in Renal Ischemia/Reperfusion Injury. , 2016, Journal of the American Society of Nephrology : JASN.

[89]  E. Cummins,et al.  Targeted delivery of the hydroxylase inhibitor DMOG provides enhanced efficacy with reduced systemic exposure in a murine model of colitis. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[90]  David K. Finlay,et al.  Immunometabolism: Cellular Metabolism Turns Immune Regulator* , 2015, The Journal of Biological Chemistry.

[91]  C. Germer,et al.  Glial cell line-derived neurotrophic factor promotes barrier maturation and wound healing in intestinal epithelial cells in vitro. , 2015, American journal of physiology. Gastrointestinal and liver physiology.

[92]  M. Moser,et al.  Cutting Edge: Hypoxia-Inducible Factor 1 Negatively Regulates Th1 Function , 2015, The Journal of Immunology.

[93]  Z. Ling,et al.  PHD3 Stabilizes the Tight Junction Protein Occludin and Protects Intestinal Epithelial Barrier Function* , 2015, The Journal of Biological Chemistry.

[94]  C. Elly,et al.  E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity. , 2015, Immunity.

[95]  E. Campbell,et al.  HIF-dependent regulation of claudin-1 is central to intestinal epithelial tight junction integrity , 2015, Molecular biology of the cell.

[96]  이지호,et al.  E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity. , 2015 .

[97]  M. Johansson,et al.  New developments in goblet cell mucus secretion and function , 2015, Mucosal Immunology.

[98]  E. Campbell,et al.  Stabilization of HIF through inhibition of Cullin‐2 neddylation is protective in mucosal inflammatory responses , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[99]  Susan R. Quinn,et al.  Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages. , 2015, Cell metabolism.

[100]  Dong-Hoon Shin,et al.  HIF-1α–Mediated Upregulation of TASK-2 K+ Channels Augments Ca2+ Signaling in Mouse B Cells under Hypoxia , 2014, The Journal of Immunology.

[101]  Sjoerd Post,et al.  The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system , 2014, Immunological reviews.

[102]  T. Mach,et al.  Clostridium difficile infection in patients with inflammatory bowel disease , 2014, Przeglad gastroenterologiczny.

[103]  S. Ramakrishnan,et al.  Hypoxia-Inducible Factor/MAZ-Dependent Induction of Caveolin-1 Regulates Colon Permeability through Suppression of Occludin, Leading to Hypoxia-Induced Inflammation , 2014, Molecular and Cellular Biology.

[104]  C. Taniguchi,et al.  PHD Inhibition Mitigates and Protects Against Radiation-Induced Gastrointestinal Toxicity via HIF2 , 2014, Science Translational Medicine.

[105]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[106]  V. Chauthaiwale,et al.  Therapeutic treatment with a novel hypoxia-inducible factor hydroxylase inhibitor (TRC160334) ameliorates murine colitis , 2014, Clinical and experimental gastroenterology.

[107]  R. Nemenoff,et al.  Transmigrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. , 2014, Immunity.

[108]  F. Formenti,et al.  Hypoxia-inducible factor 2α regulates key neutrophil functions in humans, mice, and zebrafish. , 2014, Blood.

[109]  J. Espinosa,et al.  Transcriptional regulation by hypoxia inducible factors , 2014, Critical reviews in biochemistry and molecular biology.

[110]  A. Baird,et al.  Contribution of epithelial innate immunity to systemic protection afforded by prolyl hydroxylase inhibition in murine colitis , 2013, Mucosal Immunology.

[111]  D. Laukens,et al.  Differential expression of prolyl hydroxylase 1 in patients with ulcerative colitis versus patients with Crohn’s disease/infectious colitis and healthy controls , 2013, Journal of Inflammation.

[112]  D. Finn,et al.  An apPEAling new therapeutic for ulcerative colitis? , 2013, Gut.

[113]  A. Cheong,et al.  Regulation of IL-1β–induced NF-κB by hydroxylases links key hypoxic and inflammatory signaling pathways , 2013, Proceedings of the National Academy of Sciences.

[114]  J. Greenson,et al.  Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice. , 2013, Gastroenterology.

[115]  P. Muranski,et al.  Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function. , 2013, The Journal of clinical investigation.

[116]  C. Peyssonnaux,et al.  The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions. , 2013, Blood.

[117]  R. Sumpter,et al.  Intestinal epithelial autophagy is essential for host defense against invasive bacteria. , 2013, Cell host & microbe.

[118]  J. Fandrey,et al.  Role of hypoxia inducible factor-1α for interferon synthesis in mouse dendritic cells , 2013, Biological chemistry.

[119]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[120]  W. Michalski,et al.  TLR4, IL10RA, and NOD2 mutation in paediatric Crohn’s disease patients: an association with Mycobacterium avium subspecies paratuberculosis and TLR4 and IL10RA expression , 2013, Medical Microbiology and Immunology.

[121]  D. Pardoll,et al.  Metabolic control of the Treg/Th17 axis , 2013, Immunological reviews.

[122]  Rui Chen,et al.  Allosteric Inhibition of Hypoxia Inducible Factor-2 with Small Molecules , 2013, Nature chemical biology.

[123]  E. Cummins,et al.  The Hydroxylase Inhibitor Dimethyloxallyl Glycine Attenuates Endotoxic Shock Via Alternative Activation of Macrophages and IL-10 Production by B1 Cells , 2011, Shock.

[124]  Tomohiro Watanabe,et al.  NOD2, an Intracellular Innate Immune Sensor Involved in Host Defense and Crohn's Disease , 2011, Mucosal Immunology.

[125]  P. Carmeliet,et al.  Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice. , 2011, The Journal of clinical investigation.

[126]  P. Carmeliet,et al.  Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. , 2010, Gastroenterology.

[127]  N. Reiner Macrophages and Dendritic Cells , 2009, Methods in Molecular Biology™.

[128]  S. Colgan,et al.  Selective induction of mucin‐3 by hypoxia in intestinal epithelia , 2006, Journal of cellular biochemistry.

[129]  P. Gibson,et al.  Microscopic colitis , 2002, Journal of Gastroenterology and Hepatology.

[130]  I. Leodolter [Crohn's disease]. , 1967, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete.